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ABSTRACT 
 
Mechanisms controlling endoplasmic reticulum (ER) Ca2+ homeostasis are important 
regulators of resting cytoplasmic Ca2+ concentration ([Ca2+]cyto) and receptor-mediated 
Ca2+ signalling.  Here we investigate channels responsible for ER Ca2+ leak in THP-1 
macrophage and human primary macrophage.  In the absence of extracellular Ca2+ we 
employ ionomycin action at the plasma membrane to stimulate ER Ca2+ leak.  Under 
these conditions ionomycin elevates [Ca2+]cyto revealing a Ca2+ leak response which is 
abolished by thapsigargin. IP3 receptors (Xestospongin C, 2-APB), ryanodine receptors 
(dantrolene), and translocon (anisomycin) inhibition facilitated ER Ca2+ leak in model 
macrophage, with translocon inhibition also reducing resting [Ca2+]cyto.  In primary 
macrophage, translocon inhibition blocks Ca2+ leak but does not influence resting 
[Ca2+]cyto.  We identify a role for translocon-mediated ER Ca2+ leak in receptor-mediated 
Ca2+ signalling in both model and primary human macrophage, whereby the Ca2+ 
response to ADP (P2Y receptor agonist) is augmented following anisomycin treatment.  
In conclusion, we demonstrate a role of ER Ca2+ leak via the translocon in controlling 
resting cytoplasmic Ca2+ in model macrophage and receptor-mediated Ca2+ signalling in 
model macrophage and primary macrophage. 
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1 INTRODUCTION 
 
The endoplasmic reticulum (ER) plays important roles in many cellular processes, 
including protein folding and cellular Ca2+ (Ca2+) homeostasis (Lam & Galione, 2013).  
During receptor-mediated intracellular Ca2+ signal generation, Ca2+ stored by the ER can 
be mobilised causing rapid elevation in the concentration of free cytoplasmic Ca2+ 
([Ca2+]cyto).  Receptor-mediated processes coupled to phospholipase C (PLC) mobilise 
ER Ca2+ through the production of inositol 1,4,5-triphosphate (IP3), which open IP3 
receptors on the ER membrane through which Ca2+ rapidly permeates into the 
cytoplasm (Berridge, 1993).  Released Ca2+ can stimulate further release via activation 
of ER ryanodine receptors, a process termed Ca2+-induced Ca2+ release (CICR) (Collier 
et al., 2000).  During receptor-mediated Ca2+signalling, mobilisation of the ER store 
lowers the concentration of free Ca2+ within the ER lumen ([Ca2+]ER).  The decrease in 
[Ca2+]ER is sensed by the ER resident stromal interaction molecule (STIM), which in turn 
stimulates cellular Ca2+ entry via the activation of the orai family of plasma membrane 
Ca2+ channels (Sogkas et al., 2015).  This process is termed store-operated Ca2+ entry 
(SOCE).  Receptor-mediated intracellular Ca2+ signals are therefore often a composition 
of ER Ca2+ release and Ca2+ entry via SOCE.  In macrophage, receptor-mediated Ca2+ 
signals are generated in response to environmental cues which are important for cellular 
migration (Myers & Swanson, 2002; Desai & Leitinger, 2015).  
 
 
Under resting conditions [Ca2+]ER reflects a balance between the activity of SERCA and 
passive efflux of Ca2+ into the cytoplasm via Ca2+ leak channels.  Hence the magnitude 
of ER Ca2+ leak can influence resting [Ca2+]cyto and the amount of ER Ca2+ mobilisable in 
response to receptor-mediated signalling.  The molecular identity of ER Ca2+ leak 
channels is poorly defined for mammalian cells (Camello et al., 2002).  Though 
candidates such as presenilins (Supnet & Bezprozvanny, 2011) and the ER translocon 
(Van Coppenolle et al., 2004; Amer et al., 2009; Hammadi et al., 2013) have been 
proposed as leak channels in some cell types, there is currently no published description 
of candidate channels in leukocytes. Processes of ER Ca2+ leak are therefore likely to 
play important homeostatic roles in controlling both [Ca2+]cyto and [Ca2+]ER in 
macrophage.  Understanding mechanisms of ER Ca2+ leak in macrophage is also of 
importance, as a decrease in [Ca2+]ER is a key initiator of apoptosis in ER-stressed 
macrophage, and ER Ca2+ release is necessary for apoptotic signalling in macrophage 
(Seimon et al., 2006; Lim et al., 2008).  ER-stressed mediated apoptosis in lesional 
macrophage is a central event during plaque necrosis in advanced atherosclerosis 
(Tabas et al., 2009).  In this study we sought to identify channels that mediate ER Ca2+ 
leak in human macrophage and determine the influence of ER Ca2+ leak channel activity 
on receptor-mediated Ca2+ signalling. 
 
  
2 MATERIALS AND METHODS 
 
2.1 Chemicals and reagents 
 
Ionomycin, Thapsigargin (Tg) and 2-APB were obtained from Santa-Cruz 
Biotechnologies. ADP, Anisomycin and Dantrolene were obtained from Sigma-Aldrich 
(UK). Xestospongin C was obtained from Abcam (UK).  
 
2.2 Cells 
 
THP-1 cells were obtained from the European Collection of Cell Cultures (ECACC). 
Human THP-1 cells were cultured in RPMI 1640 medium with 2mM L-glutamine, 10% 
foetal bovine serum and 50 IU/ml penicillin and 50 µg/ml streptomycin. Cells were 
maintained at 37oC with 5% CO2. To generate THP-1 differentiated macrophages, cells 
were stimulated with 320 nM of phorbol 12-myristate 13-acetate for 48h, 37oC, 5% CO2.  
 
2.3 Isolation of PBMCs and generation of monocyte-derived macrophages 
 
Peripheral venous blood was collected from healthy human volunteers through the 
National Health Service (NHS) Blood and Transplant. Blood was layered on top of 
Histopaque-1077 (Sigma-Aldrich, UK) for centrifugation at 1000 x g for 25 min. Buffy 
coat layer containing the PBMCs was removed, washed and counted using trypan blue 
exclusion. PBMCs were allowed to adhere onto T75 flasks for 2h at 37oC, washed with 
dPBS (Lonza, UK) and cultured in RPMI-160 with 2mM L-glutamine, 5% heat-inactivated 
autologous serum and 50 IU/ml penicillin and 50 µg/ml streptomycin, in the presence of 
10 ng/ml recombinant human GM-CSF (Peprotech, UK) at 37oC for 6d.  
 
2.4 Intracellular Ca2+ measurements 
 
Cells were loaded for 1h at 37oC with 2µM Fura-2 AM and measurements were made at 
37oC on a 96-well plate reader (FlexStation III, Molecular Devices). Change in 
intracellular Ca2+ concentration ([Ca2+]i) is indicated as ratio of fura-2 emission intensities 
for 340- and 380-nm excitation (F ratio). SBS buffer contained (mM): 130 NaCl, 5 KCL, 
1.2 MgCl2, 1.5 CaCl2, 8 D-glucose, 10 HEPES pH 7.4. Ca2+ free SBS was prepared by 
excluding CaCl2 and supplemented with 2mM EGTA. Loading of cells with Fura-2 was 
performed in SBS buffer supplemented with 0.01% (w/v) pluronic acid. Pre-treatment of 
all compounds, except for anisomycin (1hr), were done at 30 min. 
 
2.5 Statistical analysis 
 
Data were analysed using OriginPro 9.0 software (Origin Lab, USA). Concentration-
response curves were fitted assuming a Hill coefficient of 1. Hypothesis testing for 
experiments with paired datasets were performed by means of paired Student’s t-test 
using Origin Pro 9.0. Data are expressed as mean ± SEM of at least three independent 
experiments.  
 
 
  
3 RESULTS 
 
 
3.1 Ionomycin elevates cytoplasmic Ca2+ independent of Ca2+ influx 
 
In THP-1 model macrophage, application of ionomycin in the presence of extracellular 
Ca2+ elevated [Ca2+]cyto in a concentration-dependent manner (EC50 0.365 ± 0.01 µM; 
N=4) (Figure 1A). In the absence of extracellular Ca2+, ionomycin retained its ability to 
elevate cytoplasmic Ca2+ but with a reduced potency (EC50 0.61 ± 0.11 µM vs control 
with extracellular Ca2+; P≤0.001; N=4) and reduced maxima (F ratio 1.341 ± 0.036 vs 
2.67 ± 0.054 control µM; P≤0.001; N=4) (Figure 1A).  The kinetics of Ca2+ response 
generated by maximal concentrations of ionomycin differed in the presence or absence 
of extracellular Ca2+, with responses in the absence of extracellular Ca2+ lacking a 
sustained phase (Figure 1B). Similar results were observed in primary macrophage.  In 
primary cells, ionomycin evoked a Ca2+ response in the presence (EC50 0.332 ± 0.19 
µM; N=3) and absence of extracellular Ca2+ (EC50 3.47 ± 2.01 µM vs control with 
extracellular Ca2+; P≤0.01; N=3) (Figure 1C-D). Data from primary and model 
macrophage are consistent with the notion that ionomycin acts as a Ca2+-selective pore 
at the plasma membrane and that the sustained phase is dependent upon Ca2+ influx.  
However, the data also demonstrate that ionomycin can elevate cytoplasmic Ca2+ in the 
absence of extracellular Ca2+ and therefore in the absence of Ca2+ influx. 
 
 
3.2 Ionomycin stimulates release of ER Ca2+ store independent of Ca2+ influx 
and dependent on passive Ca2+ leak 
 
We initially investigated the requirement of the ER Ca2+ store in mediating ionomycin-
evoked responses by depleting the store with the irreversibe SERCA inhibitor 
thapsigargin (Tg).  In these experiments, Tg reduced the ability of ionomycin to elevate 
cytoplasmic Ca2+ in the presence of extracellular Ca2+ (EC50 9.28 ± 6.91 µM vs control; 
P≤0.001; N=4), though ionomycin was able to elevate cytoplasmic Ca2+ at 
concentrations 1 – 10µM (Figure 1E). However, the response to ionomycin in the 
absence of extracellular Ca2+ was abolished by Tg (Figure 1F), suggesting that 
ionomycin can elevate cytoplasmic Ca2+ independent of Ca2+ influx and dependent upon 
the ER Ca2+ store.  To further test the contribution of the ER Ca2+ store for ionomycin-
evoked response, we examined the effect of ionomycin pre-treatment of the magnitude 
of Ca2+ mobilisation following SERCA inhibition with thapsigargin.  In the presence of 
extracellular Ca2+, pre-incubation with ionomycin significantly attenuated the magnitude 
of Tg-evoked elevation in cytoplasmic Ca2+ (88.5 ± 1.93%; P≤0.001; N=4) (Figure 1G).  
In the absence of extracellular Ca2+, ionomycin pre-treatment abolished Tg-evoked Ca2+ 
response (Figure 1G). As the magnitude of Tg-evoked response in the absence of 
extracellular Ca2+ is directly proportional to the ER Ca2+ content, these data suggest 
ionomycin in the absence of extracellular Ca2+ elevates cytoplasmic Ca2+ by stimulating 
ER store mobilisation. Finally, we observed a significant elevation in basal cytoplasmic 
Ca2+ in cells pre-treated with ionomycin in the absence of extracellular Ca2+ (F ratio 1.57 
± 0.039 vs 1.96 ± 0.026 control; P≤0.001; N=4) (Figure 1H). 
 
 
 
3.3 ER Ca2+ channels mediate ionomycin-evoked cytoplasmic Ca2+ elevation in 
the absence of extracellular Ca2+ 
 
Data thus far indicate a primary role for ER Ca2+ store release in mediating the effect of 
ionomycin independent of Ca2+ influx.  On the assumption that ionomycin is acting as a 
plasma membrane conduit for Ca2+ and stimulating store leak, one would expect that ER 
Ca2+ channels underpin the response.  In initial experiments we investigated the role of 
classical ER Ca2+ release channels, namely the inositol 1,4,5-triphosphate (IP3) receptor 
and Ca2+-activated ryanodine receptors.  2-aminoethoxydiphenyl borate (2-APB) blocks 
SOCE via inhibition of both store-operated Ca2+ channels and the IP3 receptor at 
concentrations >10µM reported in other cell types.  Concurrent with this mechanism we 
observed inhibition of ionomycin-evoked Ca2+ responses both in the presence and 
absence of extracellular Ca2+ (Figure 2A-B).  In agreement with a requirement for the 
IP3 receptor in mediating ionomycin responses in the absence of extracellular Ca2+, we 
observed inhibition with xestospongin C (XeC), a membrane permeable selective IP3 
receptor antagonist (Figure 2C-D).  The inhibitory action of 2-APB and XeC in the 
absence of extracellular Ca2+ suggest that open IP3 receptors contribute to the elevation 
in cytoplasmic Ca2+ evoked by ionomycin.  Ionomycin-evoked responses were also 
inhibited by dantrolene (Figure 2E-F), revealing an involvement of ryanodine receptors 
in elevating [Ca2+]cyto. Neither 2-APB, XeC or dantrolene influence resting Ca2+ in 
macrophage.  Therefore, although a contribution of IP3 and ryanodine receptor activity to 
ER Ca2+ can be observed under experimental conditions with ionomycin present, our 
data does not support a physiological contribution of these channels to resting [Ca2+]ER.   
 
 
3.4 Effect of translocon inhibition on resting cytoplasmic Ca2+ and receptor-
mediated Ca2+ signalling 
 
It has been reported in other cell types that the ER translocon, when open, can act as a 
Ca2+ channel and can mediate ER passive Ca2+ leak.  In macrophage we employed 
anisomycin, an antibiotic inhibitor of peptidyl-transferase activity, which leaves the 
translocon closed, to test the hypothesis that the ER translocon contributes to ER Ca2+ 
leak and influences resting [Ca2+]cyto. In the absence of extracellular Ca2+, anisomycin 
(200µM) pre-treatment significantly inhibited ionomycin-evoked Ca2+ responses in THP-1 
macrophage, suggesting translocon activity can facilitate ER Ca2+ leak (Figure 3A-C).  
However, anisomycin also significantly reduced resting cytoplasmic Ca2+ in THP-1 
macrophage (F ratio 0.963 ± 0.01 vs 1.07 ± 0.01 control; P≤0.05; N=4), in contrast to the 
effect of IP3 or ryanodine receptor blockade.  These data suggest that translocon activity 
is a determinant of ER Ca2+ homeostasis and resting cytoplasmic Ca2+ concentration 
under physiological conditions.  In primary cells, the inhibitory action of anisomycin on 
the ionomycin response was observed as a reduction in net Ca2+ movement (Figure 
3E), as judged by area under the curve of the ionomycin response in the absence of 
extracellular Ca2+ (Figure 3E).  In contrast to model macrophage, anisomycin had no 
apparent effect on the resting [Ca2+]cyto.  To further test the importance of translocon 
activity in ER Ca2+ homeostasis, we examined the effect of anisomycin on receptor-
mediated Ca2+ signalling.  Our previous data shows that P2Y-mediated Ca2+ responses 
elicted by ADP in THP-1 cells are totally dependent on release of ER Ca2+ 
(Sivaramakrishnan et al., 2012), and inhibited when the ER is depleted with thapsigargin 
or ionomycin (data not shown). Translocon inhibition caused a significant increase in 
ADP potency and response maxima in both model macrophage (Figure 4A-B) and 
primary macrophage (Figure 4C-E).  These data suggest that limiting ER Ca2+ leak via 
the translocon increases the amount of ER Ca2+ mobilisation by receptor activation in 
macrophage.  Taken together, the effects of anisomycin demonstrate a role of ER Ca2+ 
leak via the translocon in controlling resting cytoplasmic Ca2+ in model macrophage and 
receptor-mediated Ca2+ signalling in model macrophage and primary macrophage. 
 
 
3.5 Summary 
 
In aggregate, under conditions of ionomycin-stimulated ER Ca2+ leak in human 
macrophage, we observe contributions of the IP3 receptor, ryanodine receptor and open 
ER translocon.  Neither IP3 receptor nor ryanodine receptor activity contribute to 
[Ca2+]cyto.  However, the activity of the translocon influences both [Ca2+]cyto in resting 
macrophage under physiological conditions, and the magnitude of receptor-mediated 
Ca2+ signals in model macrophage, in this case P2Y receptor activation.  In primary 
human macrophage, a contribution of translocon activity can be observed under 
conditions of ionomycin-stimulated Ca2+ leak, however there is no apparent contribution 
of translocon-mediated ER Ca2+ leak [Ca2+]cyto.  Despite this, inhibition of the translocon 
augments receptor-mediated Ca2+ signalling in primary cells suggesting its involvement 
in Ca2+ homeostasis during cell signalling. 
 
 
  
4 DISCUSSION 
 
The study demonstrates ER Ca2+ leak via the ER translocon as an important regulator of 
ER Ca2+ homeostasis and receptor-mediated Ca2+ signalling in human macrophage.  
Blockade of translocon-mediated Ca2+ leak from the ER using anisomycin augments the 
Ca2+ signal produced by external cues, in this study ADP, and therefore translocon 
activity is likely to modulate the ability of macrophage to respond to their environment. 
To the best of our knowledge, this is the first demonstration of the role ER translocon 
plays in controlling receptor-mediated Ca2+ signalling in leukocytes. The contribution of 
translocon-mediated leak appears more apparent in THP-1 model macrophage, where 
inhibition with anisomycin reveals a contribution to both resting [Ca2+]cyto and receptor-
mediated Ca2+ signalling, though a contribution to resting [Ca2+]cyto is not observed in 
primary cells.  Despite this, the pharmacology suggests translocon leak of ER Ca2+ does 
impact on receptor-mediated Ca2+ signalling in human primary macrophage.  We can 
also infer that the translocon is efficiently closed in primary macrophage at rest and that 
this is not the case for THP-1 model macrophage, where a leak is apparent at rest.  In 
other cell types such as vascular smooth muscle (Amer et al., 2009) and cancer cells 
(LNCaP cells; Van Coppenolle et al., 2004), the contribution of translocon-mediated ER 
Ca2+ leak has been investigated using puromycin.  In such studies, puromycin elicits an 
expectant elevation of [Ca2+]cyto, however there is no discernible contribution of 
translocon-mediated leak to receptor-mediated Ca2+ signalling (Amer M et al., 2009).  
Macrophage are highly dynamic cells and their function is tightly linked to ER Ca2+ 
homeostasis.  For example, ER stress caused by a reduction in [Ca2+]ER is a trigger for 
macrophage apoptosis (Pinton et al., 2008; Sano & Reed, 2013), and ER stress 
modulates macrophage plasticity (Oh et al., 2012). 
 
Ca2+ ionophores, like ionomycin, are generally assumed to elevate intracellular Ca2+ by 
facilitating Ca2+ transport across the plasma membrane.  In the presence of extracellular 
Ca2+, ionomycin elicits a Ca2+ response that is sustained in nature in both THP-1 model 
and human primary macrophage.  Removal of extracellular Ca2+ diminishes the 
magnitude of response, but a robust transient response persists.  Our data therefore 
indicates that ionomycin is capable of elevating intracellular Ca2+ in the absence of 
extracellular Ca2+, revealing an additional mode of action independent of Ca2+ influx.  
Ionomycin is more potent at elevated [Ca2+]cyto in the presence of extracellular Ca2+, 
reflecting a dominant contribution due to Ca2+ influx via ionomycin itself and a likely 
contribution of SOCE (Morgan & Jacob , 1994; Dedkova et al., 2000; Muller et al., 2013).  
Dedkova et al. (2000) identified a component of Ca2+ ionophore-mediated Ca2+ 
responses which was dependent on phospholipase C activity, and consequent IP3 
production.  Although we have not directly explored this pathway in macrophage, this 
may fit with our observation that open IP3 receptors participate to the apparent ER Ca2+ 
leak when ionomycin is applied in the absence of extracellular Ca2+. Open IP3 receptors 
have been identified as potential conduits of ER Ca2+ leak in other cell types (Szlufcik et 
al., 2006), where proteolytic cleavage or biochemical modification, such as 
hyperphosphorylation or nitrosylation, lead to opening of ‘uncoupled’ IP3 receptors.  In 
this current study, IP3 receptor activity was probed using antagonists XeC and 2-APB. 
While XeC is a reported selective inhibitor of IP3-induced ER Ca2+ release by 
antagonism of IP3 receptor (Gafni et al., 1997; Miyamoto et al., 2000), 2-APB is thought 
to block SOCE through two possible routes. One mode is via antagonism of the IP3 
receptor and thus preventing IP3-mediated Ca2+ release from the ER. A second route is 
via direct inhibition of store-operated Ca2+ channels at the plasma membrane. Here, we 
show that IP3 receptor activity contributes to ionomycin-evoked ER Ca2+ depletion but 
does not affect resting [Ca2+]cyto.  This study does not support a role for the IP3 receptor 
Ca2+ leakiness in resting cells, as neither antagonists influence resting [Ca2+]cyto in THP-1 
model macrophage.  These findings are similar to those observed for A7r5 rat vascular 
smooth muscle cell line where XeC or 2-APB have no influence on ER Ca2+ leak (De 
Smet et al., 1999; Missiaen et al., 2001).  
 
In this study, we observed inhibitory actions of 2-APB on ionomycin-evoked Ca2+ 
responses both in the presence and absence of extracellular Ca2+.  In the absence of 
extracellular Ca2+, the contribution of SOCE in elevating intracellular Ca2+ is negated, 
and therefore the inhibitory action of 2-APB cannot be via inhibition of plasma membrane 
Ca2+ channels.  We therefore reason that 2-APB is acting to antagonise the IP3 in THP-1 
model macrophage and thus limiting ionomycin-mediated ER Ca2+ leak in the absence of 
extracellular Ca2+.  However it is interesting to observe the ablation of responses to 
ionomycin in the absence of extracellular Ca2+ following 2-APB treatment, suggesting a 
total dependency on a 2-APB-sensitive Ca2+ conduit.  The concentration of 2-APB used 
in this study was 100µM, in other cell types this concentration has been shown to block 
SERCA (Bilmen et al., 2002) and therefore the effect of 2-APB in this study could be 
attributed to ER Ca2+ store depletion.  However, this is unlikely to be the case as 2-APB 
has no effect on resting [Ca2+]cyto, unlike thaspigargin.  Our study also reveals a role of 
ryanodine receptors in mediating the responses to ionomycin both in the presence and 
absence of extracellular Ca2+, where they likely contribute as part of Ca2+-induced-Ca2+ 
release in response to Ca2+ influx (Goussakov et al., 2010) and ER release.  Our study 
therefore identifies a major contribution of ER Ca2+ channels in mediating Ca2+ 
responses to ionomycin.  When used as a control for Ca2+ dye loaded cells, ionomycin 
must therefore be used with caution, as the ER Ca2+ state, not just plasma membrane 
influx, will influence responsivity to ionomycin. 
 
5 CONCLUSIONS 
 
In summary, we identify an important role for the ER translocon in facilitating ER Ca2+ 
leak, and regulating the amount of Ca2+ mobilisable from the ER during receptor-
mediated Ca2+ signalling in human macrophage. 
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Figure 1  Ionomycin can elevate intracellular Ca2+ independent of Ca2+ influx but 
dependent on the ER Ca2+ store.  Ionomycin-evoked intracellular Ca2+ responses in 
THP-1 model macrophage (A; N=4) and human primary macrophage (C; N=3) in the 
presence (+Ca2+) and absence (-Ca2+) of 1.5 mM extracellular Ca2+. (B, D) Averaged 
(N=3-4) time traces showing intracellular Ca2+ responses evoked by 1 µM ionomycin in 
the presence and absence of extracellular Ca2+. THP-1 macrophage responses are 
represented as absolute Fura-2 excitation/emission ratio (F ratio), and responses in 
primary macrophage are expressed normalised to maximal ionomycin-evoked response 
(F max) to control for donor variability. Dose-response curves for ionomycin-evoked Ca2+ 
responses for THP-1 macrophage in the presence (+Tg) and absence (control) of 5µM 
thapsigargin (N=4), in the presence (E) and absence (F) of 1.5mM extracellular Ca2+.  
(G) Effect of preincubation with 1µM ionomycin (iono) on the magnitude of thapsigargin 
(Tg) evoked Ca2+ response in the presence (black bar) and absence (grey bar) of 1.5 
mM extracellular Ca2+ (N=4). (H) Effect of 1µM ionomycin preincubation on resting 
cytoplasmic Ca2+ concentration (N=4) represented as absolute Fura-2 
excititation/emission ratio (F ratio).  ***P<0.001. 
 
Figure 2 Involvement of ER Ca2+ channels in mediated response to ionomycin 
in the presence and absence of extracellular Ca2+ in THP-1 macrophage. Effect of 
2-APB (100 µM) on ionomycin concentration-response in the presence (A) and absence 
(B) of 1.5 mM extracellular Ca2+ (N=3).  Effect of xestopsongin C (5 µM) on ionomycin 
concentration-response in the presence (C) and absence (D) of 1.5 mM extracellular 
Ca2+ (N=3).  Effect of dantrolene (20 µM) on ionomycin concentration-response in the 
presence (E) and absence (F) of 1.5 mM extracellular Ca2+ (N=3).   
 
Figure 3 Effect of translocon inhibition on ionomycin-evoked Ca2+ leak.  (A) 
Dose-response curves for ionomycin-evoked Ca2+ responses for THP-1 macrophage in 
the presence (+anisomycin) and absence (control) of 200 µM anisomycin (N=4), 
experiments are performed in the absence of extracellular Ca2+.  (B-C) Averaged (N=4) 
time traces from THP-1 macrophage showing intracellular Ca2+ responses evoked by 
low (0.3 µM) and high (1 µM) concentrations of ionomycin in the presence and absence 
of 200 µM anisomycin.  Experiments performed in the absence of extracellular Ca2+.  (D-
E) Effect of translocon inhibition in human primary macrophage. (D) Averaged (N=4) 
time traces from primary macrophage showing effect of 200 µM anisomycin on 
ionomycin-evoked intracellular Ca2+ response in the absence of extracellular Ca2+. (E) 
Effect of 200 µM anisomycin on net Ca2+ movement (area under the curve) evoked by 1 
µM ionomycin in the absence of extracellular Ca2+ (N=4).  *P<0.05 
 
Figure 4 ER Translocon inhibition attenuates receptor-mediated Ca2+ 
signaling.  (A)  Effect of translocon inhibition with anisomycin (200 µM) on ADP 
concentration-response curve in THP-1 macrophage (N=4).  (B)  Averaged (N=4) Ca2+ 
responses to 100 µM ADP in the presence (anisomycin) and absence (control) of 
anisomycin (200 µM).  (C) Averaged (N=4) Ca2+ responses to 100 µM ADP in human 
primary macrophage performed in the presence (anisomycin) and absence (control) of 
anisomycin (200 µM). Averaged data showing augmentation of peak response (D) and 
net Ca2+ movement (E) elicited by ADP in human primary macrophage (N=4). *P<0.05 
***P<0.001 	 	
		 	
		 	
		 	
	
